Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 126  next >
TitleAuthor(s)Issue date
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patientFroudarakis, M. E.; Briasoulis, E.24-Nov-2015
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experiencePectasides, D.; Fountzilas, G.; Aravantinos, G.; Kalofonos, H. P.; Efstathiou, E.; Salamalekis, E.; Farmakis, D.; Skarlos, D.; Briasoulis, E.; Economopoulos, T.; Dimopoulos, M. A.24-Nov-2015
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancerLinardou, H.; Briasoulis, E.; Dahabreh, I. J.; Mountzios, G.; Papadimitriou, C.; Papadopoulos, S.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015
Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group studyBriasoulis, E.; Tsokos, M.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Skarlos, D.; Nicolaides, C.; Pavlidis, N.24-Nov-2015
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implicationsHatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T.24-Nov-2015
Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literatureBriasoulis, E.; Tzouvara, E.; Tsiara, S.; Vartholomatos, G.; Tsekeris, P.; Bourantas, K.24-Nov-2015
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I studyBriasoulis, E.; Pentheroudakis, G.; Timotheadou, H.; Rammou, D.; Pavlidis, N.; Fountzilas, G.24-Nov-2015
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapyKaravasilis, V.; Briasoulis, E.; Siarabi, O.; Pavlidis, N.24-Nov-2015
Breast and gastric cancer: comparing what we learnRoukos, D. H.; Briasoulis, E.; Michos, K. M.; Elisaf, M. S.; Agnantis, N. J.; Kappas, A. M.24-Nov-2015
Cancer of Unknown Primary OriginBriasoulis, E.; Pavlidis, N.24-Nov-2015
Cancer of unknown primary site: missing primary or missing biology?Pentheroudakis, G.; Briasoulis, E.; Pavlidis, N.24-Nov-2015
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPavlidis, N.; Briasoulis, E.; Pentheroudakis, G.24-Nov-2015
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-upBriasoulis, E.; Pavlidis, N.; Felip, E.24-Nov-2015
Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-upBriasoulis, E.; Pavlidis, N.24-Nov-2015
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N.24-Nov-2015
CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survivalZagorianakou, N.; Stefanou, D.; Makrydimas, G.; Zagorianakou, P.; Briasoulis, E.; Karavasilis, B.; Agnantis, N. J.24-Nov-2015
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literatureBriasoulis, E.; Kamposioras, K.; Tzovaras, V.; Pafitanis, G.; Kostoula, A.; Mavridis, A.; Pavlidis, N.24-Nov-2015